Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 906093-29-6
2. Teneligliptin Hydrobromide
3. Unii-556rzt8jpf
4. 556rzt8jpf
5. Dtxsid90238219
6. Methanone, ((2s,4s)-4-(4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)-1-piperazinyl)-2-pyrrolidinyl)-3-thiazolidinyl-, Hydrobromide (2:5)
7. Teneligliptin Hydrobromide [jan]
8. Teneligliptin Hydrobromide [who-dd]
9. 906093-29-6 (hbr)
10. Mp-513 (hydrobromide)
11. Teneligliptin Hydrobromide (jan)
12. ((2s,4s)-4-(4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone; Hydrobromide (2:5)
13. Bis(((2s,4s)-4-(4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)methanone) Pentahydrobromide
14. ((2s,4s)-4-(4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(1,3-thiazolidin-3-yl)methanone Hemipentahydrobromide
15. {(2s,4s)-4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-yl}(1,3-thiazolidin-3-yl)methanone Hemipentahydrobromide
16. Mfcd23098790
17. Teneligliptin Hydrobromide?
18. C44h65br5n12o2s2
19. Dtxcid60160710
20. Akos040759056
21. Ac-31738
22. D11968
23. F18817
24. Q27261290
25. [(2s,4s)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone;pentahydrobromide
26. 3-[[(2s,4s)-4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]-thiazolidine Hydrobromide (2:5)
| Molecular Weight | 1257.7 g/mol |
|---|---|
| Molecular Formula | C44H65Br5N12O2S2 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 8 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 164 |
| Heavy Atom Count | 65 |
| Formal Charge | 0 |
| Complexity | 594 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 7 |
ABOUT THIS PAGE
72
PharmaCompass offers a list of 556RZT8JPF API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 556RZT8JPF manufacturer or 556RZT8JPF supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 556RZT8JPF manufacturer or 556RZT8JPF supplier.
PharmaCompass also assists you with knowing the 556RZT8JPF API Price utilized in the formulation of products. 556RZT8JPF API Price is not always fixed or binding as the 556RZT8JPF Price is obtained through a variety of data sources. The 556RZT8JPF Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 556RZT8JPF manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 556RZT8JPF, including repackagers and relabelers. The FDA regulates 556RZT8JPF manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 556RZT8JPF API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 556RZT8JPF supplier is an individual or a company that provides 556RZT8JPF active pharmaceutical ingredient (API) or 556RZT8JPF finished formulations upon request. The 556RZT8JPF suppliers may include 556RZT8JPF API manufacturers, exporters, distributors and traders.
556RZT8JPF Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 556RZT8JPF GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 556RZT8JPF GMP manufacturer or 556RZT8JPF GMP API supplier for your needs.
A 556RZT8JPF CoA (Certificate of Analysis) is a formal document that attests to 556RZT8JPF's compliance with 556RZT8JPF specifications and serves as a tool for batch-level quality control.
556RZT8JPF CoA mostly includes findings from lab analyses of a specific batch. For each 556RZT8JPF CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
556RZT8JPF may be tested according to a variety of international standards, such as European Pharmacopoeia (556RZT8JPF EP), 556RZT8JPF JP (Japanese Pharmacopeia) and the US Pharmacopoeia (556RZT8JPF USP).
